September
We at the #CrystallizationDesignInstitute are excited to announce that our graduate student Jocelyn M. Jiménez Cruz has recently published her second scientific paper (https://doi.org/10.1016/j.ijpharm.2021.121064) reporting for the first time on different polymorphic forms for MBQ-167, a small-molecule currently undergoing preclinical studies for the treatment of metastatic breast cancer. To this day, breast cancer is the most diagnosed cancer among American women. Jocelyn’s work is vital because polymorphism, the ability of molecules to crystallize in more than one crystal structure, impacts the physicochemical properties of MBQ-167 and need to be considered in the further development of MBQ-167.
We want to congratulate Jocelyn for all her efforts to develop and execute this project in collaboration with MBQ Pharma, Inc., a biopharmaceutical company based in Puerto Rico. We are extremely proud of all your accomplishments. #TeamCDI |
October
We are excited to announce our latest publication: “ Real-time concentration monitoring using a compact composite sensor array for in situ quality control of aqueous formulations” in the Journal of Pharmaceutical and Biomedical Analysis. In this publication, Mery Vet George De La Rosa and Jean P Feng Báez, explored the use of a novel compact composite sensor array (CCSA, Incentive™ Vision IR/UV probe) in collaboration with ITA Instruments Ltd. The results confirmed that the CCSA exhibited accurate monitoring of the solution and suspension concentrations in aqueous formulations in situ and real-time. Potential applications are, for instance, compact pharmaceutical manufacturing platforms.
you can read the publication following this link: https://doi.org/10.1016/j.jpba.2021.114386 |